President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.

Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug Administration — Dr. Marty Makary, a Johns Hopkins researcher, surgeon and author — as a “courageous leader” and a “reasonable choice,” who nevertheless espouses some “worrisome” views.

U.S. President-elect Donald Trump will likely choose Johns Hopkins surgeon and writer Martin Makary to lead the Food and Drug Administration, two sources familiar with the matter told Reuters on Wednesday.

Makary is a pancreatic surgeon at Johns Hopkins who became known for battling medical mistakes and in recent years has been an outspoken critic of COVID-19 policies.

President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views about the COVID-19 pandemic, to lead the Federal Drug Administration. Makary is a surgical oncologist at Johns Hopkins University and an author.